Imunon registers additional $7M in common stock under existing ATM facility

Imunon, Inc.

Filed prospectus supplement to increase ATM capacity from $10M to $17M in common stock.
Prior to filing, $4,797,848 of shares had been sold through H.C. Wainwright under the Sales Agreement.
New shares issuable under the existing May 2022 ATM agreement, as amended in 2024.

item 8.01 item 9.01

Imunon, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-012164

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.